Please assess the completion status of the following clinical trial:

Trial Title: Accent Cardiac MRI Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria~* Have an approved indication per American College of Cardiology(ACC)/ American Heart Association(AHA)/ Heart Rhythm Society(HRS)/ European Society of Cardiology(ESC) guidelines for implantation of a pacemaker~* Will receive a new dual chamber pacemaker and leads~* Be willing to undergo an elective MRI scan without complete sedation, that is ,under consciousness during MRI scan~* Be able to provide informed consent for study participation~* Be willing and able to comply with the prescribed follow-up tests and schedule of evaluations~* Is not contraindicated for an MRI scan (per the pre-MRI safety screening form)~* Age≥18 years~* Subjects must be able to undergo pectoral implantation~Exclusion Criteria~* Having an existing pacemaker or Implantable Cardioverter Defibrillator (ICD) .A new pacemaker and lead is required for enrollment~* Permanent Atrial Fibrillation/Flutter~* Are medically indicated for an MRI scan at the time of enrollment~* Have an existing active implanted medical device, e.g. neurostimulator, infusion pump etc~* Have a non-MRI compatible device or material implanted~* Have a lead extender or adaptor~* Be unable to fit in MRI bore; will come into contact with the magnet façade inside the MRI bore~* Are currently participating in a clinical investigation that includes an active treatment arm~* Are allergic to dexamethasone sodium phosphate(DSP)~* Are pregnant or planning to become pregnant during the duration of the study~* Have a life expectancy of less than 12 months due to any condition~* Subjects with exclusion criteria required by local law (e.g. age)~* Are unable to comply with the follow up schedule

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Cardiac MRI Scan Group (Type: EXPERIMENTAL): None
- Control Group (Type: NO_INTERVENTION): None

Based on this trial design, predict the completion outcome and termination type (if applicable).